Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 4, 2002
- Spin-off of Manufacturing Plants to Increase: PAL Revision
March 4, 2002
- 12,558 Drugstores Operated by 590 Companies: JACDS Survey
March 4, 2002
- Study Group Proposes Proper Drug Distribution System
March 4, 2002
- Taisho Appeals against Daikoku
March 4, 2002
- Manufacturers' FTC Issues Guide Regarding Entertainment
March 4, 2002
- Additional Premiums to Be Introduced in Medical Material Pricing System
March 4, 2002
- Kyowa Hakko to Transfer Its Liquor Business to Asahi Breweries
March 4, 2002
- Medical Devices to Be Re-priced to Reduce Domestic, Foreign Price Gaps
March 4, 2002
- Eisai's French Subsidiary Acquires All Shares of Biodim
March 4, 2002
- Fresenius-Kawasumi Completes 2nd Phase Construction on Inukai Plant
March 4, 2002
- Tsumura to Gear Up Kampo Business in China
March 4, 2002
- MEDICAL DEVICE NEWS IN BRIEF
March 4, 2002
- GE Information Supply Fee to Be Introduced: Revision -1-
March 4, 2002
- BUSINESS NEWS IN BRIEF
March 4, 2002
- WORLD NEWS IN BRIEF
March 4, 2002
- NEW PRODUCTS
March 4, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
March 4, 2002
- China Attracts Growing Number of Companies
March 4, 2002
- Dainippon to Mark Record-high Sales, Profits Again
February 25, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…